Your browser doesn't support javascript.
loading
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Taylor, Peter C; Weinblatt, Michael E; McInnes, Iain B; Atsumi, Tatsuya; Strand, Vibeke; Takeuchi, Tsutomu; Bracher, Marguerite; Brooks, David; Davies, John; Goode, Christopher; Gupta, Anubha; Mukherjee, Sumanta; O'Shea, Ciara; Saurigny, Didier; Schifano, Lorrie A; Shelton, Celia; Smith, Julia E; Wang, Millie; Wang, Reena; Watts, Sarah; Fleischmann, Roy M.
Afiliación
  • Taylor PC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK peter.taylor@kennedy.ox.ac.uk.
  • Weinblatt ME; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • McInnes IB; College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Strand V; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA.
  • Takeuchi T; Department of Internal Medicine, Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan.
  • Bracher M; Saitama Medical University, Saitama, Japan.
  • Brooks D; GSK, Stevenage, UK.
  • Davies J; GSK, Collegeville, Pennsylvania, USA.
  • Goode C; GSK, Brentford, UK.
  • Gupta A; GSK, Brentford, UK.
  • Mukherjee S; GSK, Stevenage, UK.
  • O'Shea C; GSK, Collegeville, Pennsylvania, USA.
  • Saurigny D; GSK, Dublin, Ireland.
  • Schifano LA; GSK, Stevenage, UK.
  • Shelton C; GSK, Durham, North Carolina, USA.
  • Smith JE; GSK, Collegeville, Pennsylvania, USA.
  • Wang M; GSK, Stevenage, UK.
  • Wang R; GSK, Brentford, UK.
  • Watts S; GSK, Collegeville, Pennsylvania, USA.
  • Fleischmann RM; GSK, Stevenage, UK.
Ann Rheum Dis ; 82(12): 1527-1537, 2023 12.
Article en En | MEDLINE | ID: mdl-37696589

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article